...
首页> 外文期刊>The Journal of Experomental Medicine >Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.
【24h】

Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.

机译:天然杀伤细胞刺激因子(NKSF)的鉴定和纯化,NKSF是一种对人淋巴细胞具有多种生物学作用的细胞因子。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

We have identified and purified a novel cytokine, NK cell stimulatory factor (NKSF), from the cell-free supernatant fluid of the phorbol diester-induced EBV-transformed human B lymphoblastoid cell line RPMI 8866. NKSF activity is mostly associated to a 70-kD anionic glycoprotein. The purified 70-kD protein, isolated from an SDS-PAGE gel, yields upon reduction two small species of molecular masses of 40 and 35 kD, suggesting that this cytokine is a heterodimer. When added to human PBL, purified NKSF preparations induce IFN-gamma production and synergize with rIL-2 in this activity, augment the NK cell-mediated cytotoxicity of PBL preparations against both NK-sensitive and NK-resistant target cell lines, and enhance the mitogenic response of T cells to mitogenic lectins and phorbol diesters. The three activities remain associated through different purification steps resulting in a 9,200-fold purification, and purified NKSF mediates the three biological activities at concentrations in the range of 0.1-10 pM. These data strongly suggest that the same molecule mediates these three activities, although the presence of traces of contaminant peptides even in the most purified NKSF preparations does not allow us to exclude the possibility that distinct biologically active molecules have been co-purified. The absence of other known cytokines in the purified NKSF preparations, the unusual molecular conformation of NKSF, the high specific activity of the purified protein, and the spectrum of biological activities distinguish NKSF from other previously described cytokines.
机译:我们从佛波二酯诱导的EBV转化的人B淋巴母细胞样细胞系RPMI 8866的无细胞上清液中鉴定并纯化了一种新型细胞因子NK细胞刺激因子(NKSF)。NKSF活性主要与70- kD阴离子糖蛋白。从SDS-PAGE凝胶分离出的纯化的70 kD蛋白在还原时产生两种小分子,分别为40 kD和35 kD,这表明该细胞因子是异二聚体。当将纯化的NKSF制剂添加到人PBL中时,它会诱导IFN-γ的产生并与rIL-2协同作用,增强NK细胞介导的PBL制剂对NK敏感和NK耐药的靶细胞系的细胞毒性,并增强T细胞对促有丝凝集素和佛波二酯的促有丝分裂反应。这三种活性通过不同的纯化步骤保持关联,从而产生9,200倍的纯化,并且纯化的NKSF以0.1-10 pM的浓度介导三种生物活性。这些数据有力地表明,即使在最纯化的NKSF制剂中也存在痕量的污染物肽,尽管存在痕量的污染多肽,这也不能使我们排除不同的生物活性分子被共纯化的可能性。纯化的NKSF制剂中不存在其他已知的细胞因子,NKSF的异常分子构象,纯化的蛋白的高比活性和生物学活性的谱图将NKSF与其他先前描述的细胞因子区分开来。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号